GovChime
UEI: R7EYRQWWQHU5 • CAGE: 9YW63

REVIVOCELL INC. (NY)

Registration facts

SAM.gov registration as of

SAM.gov registration
Active
Registration expiration date Sep 25, 2027

Registration

Entity structure
Corporate Entity (Not Tax Exempt)
Business start date
Nov 19, 2021 (4 years)
Location
Bronx, NY
State of incorporation
New York
Purpose of registration
All Awards

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI R7EYRQWWQHU5. GovChime does not check exclusions.

Performance

Capabilities

SBA certifications

No certification in the SBA profile data.

Business types self-reported in SAM.gov registration:

  • Self Certified Small Disadvantaged Business

Product and service codes (PSC)

  • AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
  • R425SUPPORT- PROFESSIONAL: ENGINEERING/TECHNICAL
  • AJ12GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; APPLIED RESEARCH
  • AJ13GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; EXPERIMENTAL DEVELOPMENT
  • AJ11GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH

Federal Capability Statement

Revivocell Inc. develops next-generation human-relevant microphysiological systems (MPS) for drug discovery, safety, and efficacy testing. Using its patented NANOSTACKS™ and CELLBLOKS® platforms, Revivocell recreates complex multicellular human organ and multi-organ models that incorporate physiological flow, immune competence, and AI-driven analytics. These animal-free systems enable predictive modeling of disease and drug response in liver, brain, and barrier tissues, supporting FDA Modernization Act 2.0 and Next-Generation Risk Assessment (NGRA) initiatives. The company’s PhD-level team integrates tissue engineering, stem-cell biology, and data science to deliver validated, reproducible models that accelerate translational innovation for government, pharmaceutical, and academic partners.

Contracts

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for REVIVOCELL INC. lists a physical address and a separate mailing address, along with 6 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

4345 WEBSTER AVE APT 5I

BRONX, NY, 10470

USA

Mailing Address

4345 WEBSTER AVE APT 5I

BRONX, NY, 10470

USA

Government Business Contact

Valon Llabjani

Dr

4345 webster evnue 5i

Bronx, NY, 10470

USA

Electronic Business Contact

Valon Llabjani

Dr

4345 webster avenue 5i

Bronx, NY, 10470

USA

Past Performance Contact

Valon Llabjani

Dr

4345 webster avenue 5i

Bronx, NY, 10470

USA

Government Business Alternate Contact

Valon Llabjani

Dr

4345 webster avenue app 5i

brnx, NY, 10470

USA

Electronic Business Alternate Contact

Valon Llabjani

Dr

4345 webster avenue 5i

bronx, NY, 10470

USA

Past Performance Alternate Contact

Valon Llabjani

Dr

4345 webster avenue 5i

bronx, NY, 10470

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

REVIVOCELL INC. has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires September 25, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization

Registration Details

Source: SAM.gov

Initial Registration

Jun 18, 2024

Last Update

Sep 30, 2026

Registration Activation

Active — Sep 30, 2026

Fiscal Year End

12/31

Country of Incorporation

USA

Congressional District

15